Designing Drugs with Quantum Determinism
Trias Scientific pioneers the world's first Quantum-Deterministic Drug Design (QD3) platform, fusing generative AI with rigorous quantum mechanics.
Trias Scientific pioneers the world's first Quantum-Deterministic Drug Design (QD3) platform, fusing generative AI with rigorous quantum mechanics.
Combining the speed of AI with the accuracy of quantum physics to unlock undruggable targets.
Physics-based validation ensures that every molecule designed is synthetically feasible and thermodynamically stable.
Advanced large language models explore vast chemical spaces to propose novel macrocyclic structures.
De Novo design verified with quantum computers, predicted performances before tested with CRO.
Verified design feedback to the database to enable continous evolution.
Consumer product as cashcow and pharma as high-end long-term royalty, geared as flywheel.
Mining plus analyzing plus verifying pipeline visualization.